TNF and neoplasm: The crosstalk between CAFs and tumor cells was further confirmed by the overexpression of TNF-α observed in ovarian cancer, which is determined by promoter DNA hypomethylation and chromatin remodeling, which favors TGF-α transcription in CAFs of the TME, which in turn promotes EGFR signaling, resulting in an increased metastatic ability of cancer cells.